While 96% of chief marketing officers claim AI is fundamentally transforming their departments, a chasm remains between vision and reality. Most leaders are still relegating generative AI to minor task assistance rather than adopting the autonomous, multi-agent operating systems necessary to compete in a rapidly shifting consumer landscape.
Jim Dittman, the founder and chairman of Next Level Performance, has been selected as a 2026 NJBIZ Icon Honoree. The award recognizes veteran business leaders whose professional tenure and commitment to innovation have significantly influenced the commercial landscape across New Jersey over the past several decades.
As global mandates for battery circularity tighten, the Jereh Group’s Zhengzhou facility has moved beyond pilot-phase environmental compliance to deliver industrial-scale profitability. By processing 15,000 tons of feedstock with high recovery purity, the company is positioning its automated recycling technology as a strategic solution for the tightening global lithium supply chain.
The global MicroLED interconnect market is bracing for a surge as artificial intelligence and high-performance computing demand alternatives to copper-based systems. Valued at $181.6 million in 2025, the sector is projected to reach $722 million by 2033, driven by the need for faster, energy-efficient data transmission.
More than 1,000 representatives from across the globe gathered at the Linshui Palace in Gutian County this week to honor the legacy of Chen Jinggu. The three-day event, held as part of the 18th Straits Forum, serves as a cornerstone for fostering shared cultural identity and cooperation between Fujian and Taiwan.
The BC.GAME platform token, $BC, climbed above the $0.01 threshold on June 14, 2026, hitting a peak of $0.0116. This 23% single-day spike reflects growing investor interest in the platform’s restructured reward mechanics and the expanding utility of its native digital asset within the broader gaming ecosystem.
Singapore-based intelligence platform fileAI is expanding into Japan through a strategic partnership and investment from JRE VENTURES, the corporate venture capital arm of the JR East Group. The collaboration focuses on deploying AI agents to digitize and restructure legacy contractual archives within the Japanese infrastructure giant’s diverse operations.
For parents grappling with the relentless encroachment of digital screens, the Shenzhen-based developer Haivivi offers a tactile alternative: BubblePal. This compact, pendant-style device attaches to existing plush toys, granting them the ability to converse, remember past interactions, and provide real-time, emotionally intelligent feedback to children aged three to eight.
As Washington D.C. observes WANDA Week from June 14–20, the organization celebrates a decade of elevating Black women in agriculture and nutrition. This year’s programming, anchored by the theme "Rooted in Joy and Justice," honors historical legacies while securing financial support for the next generation of food system leaders.
Standing at 20,312 feet on the summit of Mount Chimborazo, a Unitree G1 humanoid robot named Pemba has completed the highest-altitude expedition of its kind. The June 5 mission, organized by Geologic Dome and Eastworlds Labs, serves as a rigorous stress test for autonomous AI in extreme alpine environments.
Following a high-level summit between Prime Ministers Sanae Takaichi and Keir Starmer in London, Japan’s Rapidus Corporation has formalized a partnership with the UK Semiconductor Centre. The agreement aims to integrate British design expertise with Japanese manufacturing capacity to secure future supply chains for advanced logic semiconductors.
At the 2026 European Hematology Association congress, CARsgen Therapeutics unveiled clinical data for its allogeneic CAR T-cell candidates, CT0596 and CT1190B. The results highlight promising efficacy and safety profiles for patients with relapsed or refractory multiple myeloma and B-cell non-Hodgkin's lymphoma, signaling a potential shift in cell therapy accessibility.
A Delaware jury has ruled that Amgen and its subsidiary Teneobio willfully infringed on a foundational antibody discovery patent held by Harbour BioMed. The verdict, delivered after a brief three-hour deliberation, awards the biopharmaceutical company $20.2 million and validates the integrity of its proprietary transgenic rodent technology.
Bambu Lab has launched its 4th Anniversary Sale, marking the first time the company has applied discounts to its P2S, H2S, and H2C 3D printer models. The month-long event runs from June 15 through July 15, offering reduced pricing across the US, EU, UK, Canada, and Australian markets.
Bambu Lab is marking its fourth anniversary with a global sale running from June 15 through July 15, 2026, offering unprecedented discounts on its 3D printer lineup. The promotion includes the first-ever price reductions for the P2S, H2S, and H2C models across markets in the US, Europe, and beyond.
Consumers are increasingly bypassing mass-produced items in favor of deeply personalized Father’s Day gifts, pushing small businesses and makers toward high-precision laser engraving. This shift highlights a broader retail trend where sentimental value and customization have become the primary drivers for holiday sales performance.
Jason Christie did not believe he was destined for a win until the trophy was in his hands. The Oklahoma pro secured his second victory of the 2026 season at the Maxam Bassmaster Elite Series, finishing with a four-day total of 92 pounds, 7 ounces despite struggling to maintain a consistent pattern.
A class action lawsuit filed in Orange County Superior Court accuses Empyrean Anaheim Resort, Inc. of systemic labor violations, including the denial of mandatory meal and rest periods. The complaint, brought by Blumenthal Nordrehaug Bhowmik De Blouw LLP, alleges the resort manipulated time records to avoid paying legally required penalties.
Investors who purchased Phreesia, Inc. common stock between May 8, 2025, and March 30, 2026, have until July 13, 2026, to apply for lead plaintiff status in a pending class action lawsuit. The litigation targets alleged misrepresentations regarding the company’s slowing demand and weakened pharmaceutical marketing revenue.
Investors who purchased GeneDx Holdings Corp. securities between April 16, 2025, and May 4, 2026, are being alerted to a securities fraud class action lawsuit. The filing follows a massive share price decline triggered by disappointing first-quarter results and a significant impairment charge related to the company’s acquisition of Fabric Genomics.
A new concept study suggests that PMET Resources could bypass traditional offshore refining by processing spodumene concentrate directly at its Shaakichiuwaanaan site in Quebec. By adopting an atmospheric leach process, the company aims to leverage local hydroelectric power to produce battery-grade lithium carbonate while cutting logistics-heavy transport costs.
Investors who purchased Verra Mobility Corporation common stock between February 24 and May 26, 2026, are being sought to join a pending securities class action lawsuit. Rosen Law Firm, representing the plaintiffs, has set an August 4, 2026, deadline for those wishing to serve as lead plaintiff in the litigation.
As physical performance and long-term mobility become central to aging well, Manassas-based PureHealth Research is positioning its latest supplement line to address the intersection of strength training and recovery through a blend of magnesium, ashwagandha, and omega-3 fatty acids.
Investors who held FLOW cryptocurrency between December 27 and December 29, 2025, are being urged to contact the Rosen Law Firm. The firm is currently investigating potential securities claims against the Flow Foundation, alleging the organization disseminated materially misleading business information to the public.
The Orbis Flying Eye Hospital has touched down in Arequipa, Peru, launching a two-week intensive training program for local medical professionals. In collaboration with the Ministry of Health and Hospital Regional Honorio Delgado Espinoza, the mission aims to bolster ophthalmic care across the country’s southern, often underserved, regions.
A 22% plunge in Disc Medicine’s stock price on February 13, 2026, has triggered a formal investigation by Rosen Law Firm. The legal action centers on allegations that the biotech company misled shareholders regarding the viability of its bitopertin drug program, which recently failed to secure FDA approval.
Nearly 90% of confirmed Ebola cases in the Democratic Republic of Congo are concentrated in the Ituri Province, prompting Samaritan's Purse to launch two emergency field hospitals. These facilities in Bunia and Nyankunde aim to isolate patients and provide urgent care as the viral outbreak continues to climb.
At 8:30 a.m. on Monday, June 15, 2026, the team at Tradr ETFs will ring the Opening Bell at Cboe Global Markets. The ceremony marks the debut of the Tradr 2X Long SpaceX Daily ETF (SPCM) and the Tradr 2X Short SpaceX Daily ETF (SPCG), both designed for high-conviction, short-term trading.
The combination of selinexor and ruxolitinib has met a primary endpoint in the Phase 3 SENTRY trial, demonstrating a statistically significant reduction in spleen volume for patients with frontline myelofibrosis. Presented at the EHA 2026 Congress, the results highlight a potential shift in treatment efficacy for this rare blood cancer.
Adding Eli Lilly’s pirtobrutinib to a standard venetoclax and rituximab regimen significantly improved outcomes for patients with relapsed or refractory chronic lymphocytic leukemia, according to results from the Phase 3 BRUIN CLL-322 trial presented ahead of the 2026 European Hematology Association Annual Meeting.
